1. Fowler VG, Scheld WM, Bayer AS. Mandell GL, Bennett JE, Dolin R, editors. Endocarditis and intravascular infections. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 2005. 6th ed. New York: Churchill Livingstone;975.
Article
2. Lee WK, Mossop PJ, Little AF, Fitt GJ, Vrazas JI, Hoang JK, Hennessy OF. Infected (mycotic) aneurysms: spectrum of imaging appearances and management. Radiographics. 2008. 28:1853–1868.
Article
3. Brown SL, Busuttil RW, Baker JD, Machleder HI, Moore WS, Barker WF. Bacteriologic and surgical determinants of survival in patients with mycotic aneurysms. J Vasc Surg. 1984. 1:541–547.
Article
4. Katlic MR, Derkac WM, Coleman WS. Clostridium septicum infection and malignancy. Ann Surg. 1981. 193:361–364.
Article
5. Kornbluth AA, Danzig JB, Bernstein LH. Clostridium septicum infection and associated malignancy. Report of 2 cases and review of the literature. Medicine (Baltimore). 1989. 68:30–37.
6. Sailors DM, Eidt JF, Gagne PJ, Barnes RW, Barone GW, McFarland DR. Primary Clostridium septicum aortitis: a rare cause of necrotizing suprarenal aortic infection. A case report and review of the literature. J Vasc Surg. 1996. 23:714–718.
Article
7. Drasar BS, Goddard P, Heaton S, Peach S, West B. Clostridia isolated from faeces. J Med Microbiol. 1976. 9:63–71.
Article
8. Moore WE, Holdeman LV. Human fecal flora: the normal flora of 20 Japanese-Hawaiians. Appl Microbiol. 1974. 27:961–979.
Article
9. Holdeman LV, Good IJ, Moore WE. Human fecal flora: variations in bacterial compositions within individuals and a possible effect of emotional stress. Appl Environ Microbiol. 1974. 31:359–375.
Article
10. Leal J, Gregson DB, Ross T, Church DL, Laupland KB. Epidemiology of Clostridium species bacteremia in Calgary, Canada, 2000-2006. J Infect. 2008. 57:198–203.
Article
11. Alpern RJ, Dowell VR Jr. Clostridium septicum infection and malignancy. JAMA. 1969. 209:385–388.
12. Malmgren RA, Flanigan CC. Localization of the vegetative form of Clostridium tetani in mouse tumors following intra venous spore administration. Cancer Res. 1955. 15:473–478.
13. Thiele EH, Arison RN, Boxer GE. Oncolysis by clostridia. IV. Effect of nonpathogcnic clostridial spores in normal and pathological tissues. Cancer Res. 1964. 24:234–238.
14. Jendrzejewski JW, Jones SR, Newcombe RL, Gilbert DN. Nontraumatic clostridial myonecrosis. Am J Med. 1978. 65:542–546.
Article
15. Pelletier JP, Plumbley JA, Rouse EA, Cina SJ. The role of Clostridium septicum in paraneoplastic sepsis. Arch Pathol Lab Med. 2000. 124:353–356.
Article
16. Mohamed HK, Elliott BM, Brothers TE, Robison JG. Suprarena1 Clostridium septicurn aortitis with rupture and simultaneous colon cancer. Ann Vasc Surg. 2006. 20:825–829.
Article
17. Cin CS, Arena GO, Fiture AO, Clase CM, Doobay B. Ruptured mycotic thoracoabdominal aortic aneurysms: a report of three cases and a systematic review. J Vasc Surg. 2001. 33:861–867.
Article
18. Wein M, Bartel T, Kabatnik M, Sadony V, Dirsch O, Erbel R. Rapid progression of bacterial aortitis to an ascending aortic mycotic aneurysm documented by transesophageal echocardiography. J Am Soc Echocardiogr. 2001. 14:646–649.
Article
19. Knosalla C, Weng Y, Yankah AC, Hofmeister J, Hetzer R. Using aortic allograft material to treat mycotic aneurysms of the thoracic aorta. Ann Thorac Surg. 1996. 61:1146–1152.
Article
20. Moneta GL, Taylor LM Jr, Yeager RA, Edwards JM, Nicoloff AD, McConnell DB, Porter JM. Surgical treatment of infected aortic aneurysm. Am J Surg. 1998. 175:396–399.
Article